All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...778Next →

hiv & aids news selected from other sources

  • People and personal stories
    On Treatment and Uninfectious, Women With HIV Still Shamed by Misinformed Providers, Public
    The Body | 11 hours ago

    Many women with suppressed viral loads still experience shame around their status. Many are convinced they're undesirable. Some worry they're still infectious. Others may take extra precautions during sex or avoid the act all together. Then there are those positive women who forego motherhood despite wanting children.

  • New and experimental hepatitis C treatment
    Achillion Announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen’s Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naïve HCV
    Achillion press release | 16 hours ago

    The e-poster presented at EASL / AASLD Special Conference: New Perspectives in Hepatitis C Virus Infection – The Roadmap For Cure reports that 100 percent of patients receiving treatment for as short as six weeks with a triple combination of once-daily (QD) AL-335 800mg and simeprevir (SMV) 75mg with 50mg every other day (QOD) of ODV achieved a sustained viral response 12 weeks after the completion of treatment (SVR12).

  • Hepatitis C treatment
    NICE says yes to another hepatitis C drug
    NICE | 16 hours ago

    NICE has published new draft guidance which recommends sofosbuvir-velpatasvir (Epclusa) – an anti-viral drug that offers patients with chronic hepatitis C a potential cure.

  • Hepatitis C treatment
    Exviera, Viekirax regimen shows high SVR in HCV genotype 1b after 8 weeks
    Healio | 16 hours ago

    New data from the GARNET study — presented today in Paris at the 2016 EASL Special Conference: New Perspectives in Hepatitis C Virus Infection – The Roadmap for Cure — showed 98% of patients with hepatitis C virus genotype 1b infection without cirrhosis achieved sustained virologic response 12 weeks after treatment with Exviera plus Viekirax without ribavirin, with some showing high rates after 8 weeks.

  • Sex workers
    Edinburgh's blind-eye prostitution policy 'launched in the 1980s amid HIV fears'
    Herald Scotland | 17 hours ago

    A SO-CALLED blind-eye policy to prostitution in the Scottish capital was an official attempt to minimise the impact of HIV and Aids in the city. It has emerged the policy had been formalised and involved the then Lothian and Borders Police, Edinburgh. Saunas were allowed to operate as they were said to be providing workers with condoms and critical health advice.

  • Discrimination and the law
    6 Nursing Homes Accused of HIV Discrimination
    Poz | 22 September 2016

    The facilities allegedly refused to accept a client because of his HIV, according to the ACLU.

  • PrEP
    Inside the Fight to Make a Revolutionary HIV Medication Widely Available
    VICE | 22 September 2016

    The controversial anti-HIV drug PrEP (or Truvada) is widely seen as a medicine for gay men. We speak to trans people, sex workers and black community leaders who believe that they need PrEP, too.

  • Global health initiatives
    Fuzzy Math at the Global Fund Replenishment?
    Medium | 22 September 2016

    Why $13 billion might not be $13 billion and why it’s insufficient even if it is.

  • Transgender people
    Why I believe everyone should have easy and affordable access to PrEP
    Gay Star News | 21 September 2016

    Trans man Jamie Jaxon takes PrEP to prevent becoming HIV positive. Here he explains why NHS England should provide the treatment.

  • Global health initiatives
    Global Fund sees new donors, persistent gaps
    Devex | 21 September 2016

    The Global Fund to Fight AIDS, Tuberculosis and Malaria hit its funding goal at the fifth replenishment conference in Montreal, Canada, on Sept 16-17. But advocates warn that those funds may still fall short of what’s needed to reach the most vulnerable communities. The reasons include persistent human rights challenges and access to affordable drugs — both of which require new financing and better policy, advocates said.

← First12345...1235Next →

Conference news

News from the 21st International AIDS Conference (AIDS 2016)

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close